Deficiency of cyclin-dependent kinase inhibitors p21Cip1 and p27Kip1 accelerates atherogenesis in apolipoprotein E-deficient mice
- 24 April 2010
- journal article
- research article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 396 (2), 359-363
- https://doi.org/10.1016/j.bbrc.2010.04.097
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Absence of p21 Waf1/Cip1/Sdi1 Modulates Macrophage Differentiation and Inflammatory Response and Protects Against AtherosclerosisCirculation, 2004
- Mutated p21/WAF/CIP transgene overexpression reduces smooth muscle cell proliferation, macrophage deposition, oxidation‐sensitive mechanisms, and restenosis in hypercholesterolemic apolipoprotein E knockout miceThe FASEB Journal, 2001
- The growth suppressor p27 Kip1 protects against diet‐induced atherosclerosisThe FASEB Journal, 2001
- p27–p16 Chimera: A Superior Antiproliferative for the Prevention of Neointimal HyperplasiaMolecular Therapy, 2001
- Proteinases in cardiovascular aneurysms and rupture: targets for therapy?JCI Insight, 2000
- Downregulation of cyclin-dependent kinase 2 activity and cyclin A promoter activity in vascular smooth muscle cells by p27(KIP1), an inhibitor of neointima formation in the rat carotid artery.JCI Insight, 1997
- Enhanced Growth of Mice Lacking the Cyclin-Dependent Kinase Inhibitor Function of p27Cell, 1996
- Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty.JCI Insight, 1995
- Inhibitors of mammalian G1 cyclin-dependent kinases.Genes & Development, 1995
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993